NCT05478681 is a NA clinical trial of active tDCS in Alzheimer Disease, sponsored by The University of Texas Health Science Center, Houston.

Who is sponsoring NCT05478681?

NCT05478681 is sponsored by The University of Texas Health Science Center, Houston.

What drugs are being tested in NCT05478681?

Interventions in NCT05478681: active tDCS.

What condition does NCT05478681 study?

NCT05478681 studies Alzheimer Disease.

Is NCT05478681 still recruiting?

NCT05478681 is currently completed. Last updated 10 October 2025.

Are results published for NCT05478681?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2025-10-10 · How we verify

NCT05478681

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD)

Completed NA Results posted Last updated 10 October 2025

What this trial tests

NA trial testing active tDCS in Alzheimer Disease in 3 participants. Completed in 26 February 2024.

Timeline

17 April 2023

Primary endpoint
26 February 2024

26 February 2024

Quick facts

Lead sponsor	The University of Texas Health Science Center, Houston
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	3
Start date	17 April 2023
Primary completion	26 February 2024
Estimated completion	26 February 2024
Sites	2 locations across United States

Drugs / interventions tested

active tDCS

Conditions studied

Alzheimer Disease — all drugs for Alzheimer Disease →

Sponsor

The University of Texas Health Science Center, Houston

Who can join

60 and older, any sex, with Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess acceptability, and safety of providing tDCS to ADRD patients with behavioral symptoms and to assess the efficacy of tDCS for ADRD-related symptoms, mainly behavioral symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of active tDCS

Trials testing the same drug.

NCT06678529 — Effect of Transcranial Direct Current Stimulation on Postoperative Delirium in Elderly Patients · NA · recruiting
NCT06453980 — Multimodal Investigation of Neural Plasticity · NA · recruiting
NCT06432465 — tDCS to Decrease Opioid Relapse (UH3) · NA · recruiting
NCT07273175 — Effects of Transcranial Direct Current Stimulation on Cognitive Rehabilitation in Schizophrenia · NA · enrolling by invitation
NCT05326451 — Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Dise · NA · recruiting

Other recruiting trials for Alzheimer Disease

Currently open trials in the same condition.

NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
NCT07178210 — Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease · NA · recruiting
NCT07294885 — Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease · NA · recruiting
NCT06937229 — A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · recruiting
NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05478681 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
Last refreshed: 10 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05478681.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing